| Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection ARN Zekri, ASED Youssef, ED El-Desouky, OS Ahmed, MM Lotfy, ... Tumor Biology 37, 12273-12286, 2016 | 104 | 2016 |
| Circulating serum miRNAs as diagnostic markers for colorectal cancer ARN Zekri, ASED Youssef, MM Lotfy, R Gabr, OS Ahmed, A Nassar, ... PloS one 11 (5), e0154130, 2016 | 74 | 2016 |
| Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation AERN Zekri, AAM Nassar, MNED El-Rouby, HI Shousha, AB Barakat, ... Asian Pacific Journal of Cancer Prevention 14 (11), 6721-6726, 2013 | 48 | 2013 |
| Targeted next generation sequencing identifies somatic mutations in a cohort of Egyptian breast cancer patients A Nassar, M Abouelhoda, O Mansour, SA Loutfy, MM Hafez, M Gomaa, ... Journal of Advanced Research 24, 149-157, 2020 | 18 | 2020 |
| MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection ARN Zekri, ER El-Sisi, ASED Youssef, MM Kamel, A Nassar, OS Ahmed, ... PLoS One 13 (3), e0193709, 2018 | 14 | 2018 |
| Promotor methylation: Does it affect response to therapy in chronic hepatitis C (G4) or fibrosis? ARN Zekri, AM Raafat, S Elmasry, AA Bahnassy, Y Saad, HA Dabaon, ... Annals of Hepatology 13 (5), 518-524, 2015 | 12 | 2015 |
| Frequency of pathogenic germline mutations in early and late onset familial breast cancer patients using multi-gene panel sequencing: an Egyptian study A Nassar, ARN Zekri, MM Kamel, MH Elberry, MM Lotfy, MG Seadawy, ... Genes 14 (1), 106, 2022 | 6 | 2022 |
| Multigene panel sequencing reveals cancer-specific and common somatic mutations in colorectal cancer patients: an Egyptian experience ASED Youssef, MA Abdel-Fattah, MM Lotfy, A Nassar, M Abouelhoda, ... Current issues in molecular biology 44 (3), 1332-1352, 2022 | 6 | 2022 |
| Tumor mutation burden prediction model in Egyptian breast cancer patients based on next generation sequencing A Nassar, AM Lymona, MM Lotfy, ASED Youssef, M Mohanad, TM Manie, ... Asian Pacific Journal of Cancer Prevention: APJCP 22 (7), 2053, 2021 | 5 | 2021 |
| Serum MicroRNAs as differential markers and a molecular therapeutic target for HCV associated liver disease: 420 A Zekri, AS Youssef, GE Esmat, I Hammad, EA Ahmed, O Ahmed, ... Hepatology 58, 410A-411A, 2013 | 4 | 2013 |
| Deep Next Generation Sequencing Identifies Somatic Mutational Signature in Egyptian Colorectal Cancer Patients A Youssef, MA Abdel-Fattah, AO Touny, ZK Hassan, A Nassar, MM Lotfy, ... | 1 | 2020 |
| Revealing mismatch repair deficiency in Egyptian colorectal cancer patients using next generation sequencing a predictive biomarker for immunotherapy efficacy ASED Youssef, M Ragab, HA Ateya, M Elberry, N Fathy, A Elleithy, ... Cancer Research 84 (6_Supplement), 3854-3854, 2024 | | 2024 |
| Deleterious and ethnic-related BRCA1/2 mutations in tissue and blood of Egyptian colorectal cancer patients and its correlation with human papillomavirus ASED Youssef, ARN Zekri, M Mohanad, SA Loutfy, NF Abdel Fattah, ... Clinical and Experimental Medicine 23 (8), 5063-5088, 2023 | | 2023 |
| Somatic Mutations Alter Interleukin Signaling Pathways in Grade II Invasive Breast Cancer Patients: An Egyptian Experience A Nassar, ARN Zekri, MH Elberry, AM Lymona, MM Lotfy, M Abouelhoda, ... Current Issues in Molecular Biology 44 (12), 5890-5901, 2022 | | 2022 |
| The mutational pattern of cell cycle checkpoints and regulators in Egyptian colorectal cancer patients AS El-Din Youssef, MM Lotfy, A Nassar, ARN Zekri Cancer Research 81 (13_Supplement), 1964-1964, 2021 | | 2021 |
| Tumor mutation burden of Egyptian breast cancer patients based on next generation sequencing A Nassar, AM Lymona, MM Lotfy, AS El-Din Youssef, ARN Zekri Cancer Research 81 (13_Supplement), 257-257, 2021 | | 2021 |
| Identification of Somatic BRCA1/2 mutation profile in tissue-based and liquid biopsy-based next generation sequencing in Egyptian patients with breast cancer MM Lotfy, ASED Youssef, A Nassar, M Kamel, ZK Hassan, ... Cancer Research 81 (13_Supplement), 2175-2175, 2021 | | 2021 |
| Abstract PO-131: Therapeutic molecular targets in Egyptian colorectal cancer patients: Time for ethnic personalized medicine AS El-Din Youssef, A Nassar, MM Lotfy, MA Abdel-Fattaf, ARN Zekri Cancer Epidemiology, Biomarkers & Prevention 29 (12_Supplement), PO-131-PO-131, 2020 | | 2020 |
| Abstract PO-124: Mutational profiling of DNA repair and mismatch repair genes in the Egyptian colorectal cancer patients using targeted DNA sequencing AS El-Din Youssef, MM Lotfy, A Nassar, ARN Zekri Cancer Epidemiology, Biomarkers & Prevention 29 (12_Supplement), PO-124-PO-124, 2020 | | 2020 |
| Targeted next generation sequencing identifies somatic variants in Egyptian breast cancer patients A Nassar, M Abouelhoda, A Bahnassy, AS El-Din Youssef, MM Lotfy, ... Cancer Research 80 (16_Supplement), 2491-2491, 2020 | | 2020 |
